| Title |
Adverse drug reactions caused by drug–drug interactions in elderly outpatients: a prospective cohort study
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, May 2012
|
| DOI | 10.1007/s00228-012-1309-3 |
| Pubmed ID | |
| Authors |
Paulo Roque Obreli-Neto, Alessandro Nobili, André de Oliveira Baldoni, Camilo Molino Guidoni, Divaldo Pereira de Lyra Júnior, Diogo Pilger, Juliano Duzanski, Mauro Tettamanti, Joice Mara Cruciol-Souza, Walderez Penteado Gaeti, Roberto Kenji Nakamura Cuman |
| Abstract |
Although the prevalence of drug-drug interactions (DDIs) in elderly outpatients is high, many potential DDIs do not have any actual clinical effect, and data on the occurrence of DDI-related adverse drug reactions (ADRs) in elderly outpatients are scarce. This study aimed to determine the incidence and characteristics of DDI-related ADRs among elderly outpatients as well as the factors associated with these reactions. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 148 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 7 | 5% |
| Israel | 1 | <1% |
| United States | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 138 | 93% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 24 | 16% |
| Student > Bachelor | 18 | 12% |
| Student > Postgraduate | 17 | 11% |
| Student > Ph. D. Student | 14 | 9% |
| Researcher | 13 | 9% |
| Other | 29 | 20% |
| Unknown | 33 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 48 | 32% |
| Pharmacology, Toxicology and Pharmaceutical Science | 36 | 24% |
| Nursing and Health Professions | 6 | 4% |
| Social Sciences | 4 | 3% |
| Chemistry | 4 | 3% |
| Other | 14 | 9% |
| Unknown | 36 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2022.
All research outputs
#8,262,193
of 26,017,215 outputs
Outputs from European Journal of Clinical Pharmacology
#944
of 2,829 outputs
Outputs of similar age
#56,933
of 182,808 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#9
of 33 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 2,829 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 182,808 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.